4/18/2013 11:40:05 AM
LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma, Inc. (OTCQB: TRGM) (the “Company”), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced that its Form S-1 registration statement (the “Registration Statement”), which registers up to 25,723,395 shares of common stock (“Shares”) for resale by selling stockholders on a delayed or continuous basis, has cleared comments with the United States Securities and Exchange Commission and accordingly, the Company has requested the Registration Statement be declared effective at 4:00 p.m. EST on April 19, 2013. The Company will not receive any proceeds from the sale of the Shares by the selling stockholders. All the proceeds from any sale of the Shares will be for the respective account of each selling stockholder. The final prospectus related to the Registration Statement can be accessed through EDGAR via www.sec.gov.
comments powered by